Last reviewed · How we verify
NCT06739772: HOPE
Development of Implementation Toolkits
NA trial testing HPV Self-Sampling and Behavior Intervention in Self Sampling in 108 participants. Not yet recruiting.
31 October 2025
Quick facts
| Lead sponsor | Baylor University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 108 |
| Start date | 10 February 2025 |
| Primary completion | 31 October 2025 |
| Estimated completion | 3 November 2025 |
| Sites | 1 location across Ghana |
Drugs / interventions tested
- HPV Self-Sampling and Behavior Intervention
- Participants in the intervention group will receive HPV self sampling and behavioral intervention
Conditions studied
- Self Sampling — all drugs for Self Sampling →
- Communication Model — all drugs for Communication Model →
- Implementation Science — all drugs for Implementation Science →
- HIV — all drugs for HIV →
Sponsor
Baylor University
Who can join
Adults 25 to 65, female only, with Self Sampling or Communication Model. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to conduct an intervention program aimed at increasing HPV self-sampling among women living with HIV in Ghana.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
HPV self-sampling for cervical cancer screening among women living with HIV in Ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial.
Asare M, Obiri-Yeboah D, Ken-Amoah S, Akakpo PK, et al · · 2025 · cited 2× · PMID 41299750 · DOI 10.1186/s13063-025-09262-2 -
Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
Asare M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al · · 2025 · PMID 41475829 · DOI 10.1136/bmjopen-2025-105852
Verify or expand the search:
- PubMed search for NCT06739772
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Baylor University trials
Trials by the same sponsor.
- NCT07452900 — Using Integrated Care and Wearable Technology to Evaluate Outcomes of the Shields & Stripes Program for Veterans and Fir · not yet recruiting
- NCT07185737 — Culturally Adapted RUBI-T for Spanish-Speaking Families in Texas and Mexico · NA · not yet recruiting
- NCT07460609 — Exploring Blood Flow Restriction as an Accessible Fitness Solution for Healthy Aging in Seniors · NA · active not recruiting
- NCT06906107 — Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief · NA · recruiting
- NCT06718803 — A Mobile App for Hot Flashes and Sleep Disturbances · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06739772 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor University
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06739772.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing